Athenex News - ATNX

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Athenex Inc ATNX NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.31 -3.03% 9.92 10.355 9.82 10.34 10.23 09:48:52
more quote information »

Recent News

Date Time Source Heading
10/18/201918:01EDGARStatement of Changes in Beneficial Ownership (4)
10/18/201916:06EDGARStatement of Changes in Beneficial Ownership (4)
10/17/201916:12EDGARStatement of Changes in Beneficial Ownership (4)
10/16/201916:31EDGARStatement of Changes in Beneficial Ownership (4)
9/30/201916:13EDGARStatement of Changes in Beneficial Ownership (4)
9/30/201916:09EDGARStatement of Changes in Beneficial Ownership (4)
9/25/201916:40EDGARStatement of Changes in Beneficial Ownership (4)
9/23/201916:09EDGARStatement of Changes in Beneficial Ownership (4)
9/23/201907:00GLOBEAthenex to Highlight Oral Paclitaxel Clinical Programs..
9/18/201917:31EDGARStatement of Changes in Beneficial Ownership (4)
9/16/201919:31EDGARStatement of Changes in Beneficial Ownership (4)
9/16/201916:26EDGARStatement of Changes in Beneficial Ownership (4)
9/11/201907:00GLOBEAthenex Announces Initiation of Phase I Clinical Study in..
9/09/201907:02EDGARCurrent Report Filing (8-k)
9/04/201907:00GLOBEAthenex Announces Appointment of Daniel Lang MD to Lead..
8/23/201916:09EDGARStatement of Changes in Beneficial Ownership (4)
8/16/201917:31EDGARStatement of Changes in Beneficial Ownership (4)
8/16/201916:14EDGARStatement of Changes in Beneficial Ownership (4)
8/15/201916:15EDGARStatement of Changes in Beneficial Ownership (4)
8/09/201917:57EDGARStatement of Changes in Beneficial Ownership (4)
8/07/201909:03EDGARQuarterly Report (10-q)
8/07/201906:33EDGARCurrent Report Filing (8-k)
8/07/201906:00GLOBEAthenex, Inc. Announces Second Quarter 2019 Financial..
8/02/201909:16EDGARCurrent Report Filing (8-k)
8/02/201908:00GLOBEAthenex Provides an Update Regarding the Vasopressin Case
7/29/201908:00GLOBEAthenex, Inc. to Report Second Quarter 2019 Earnings Results..
7/23/201916:53EDGARAutomatic Shelf Registration Statement of Securities of..
6/28/201907:00GLOBEAthenex Announces Strategic Global Initiatives to Expand..
6/27/201908:00GLOBESunGen Pharma Announces to Partner with Athenex..
6/24/201907:00GLOBEAthenex Announces U.S. FDA Allowance of Investigational New..
6/13/201907:01EDGARCurrent Report Filing (8-k)
6/07/201917:00EDGARAmended Statement of Ownership (sc 13g/a)
6/07/201916:19EDGARStatement of Changes in Beneficial Ownership (4)
6/06/201907:07EDGARCurrent Report Filing (8-k)
6/06/201907:00GLOBEAthenex and PharmaEssentia Announce Positive Early Signals..
5/30/201907:00GLOBEAthenex to Present at the 2019 ASCO Annual Meeting
5/15/201906:16EDGARSmall Company Offering and Sale of Securities Without..
5/09/201908:40EDGARQuarterly Report (10-q)
5/09/201907:06EDGARCurrent Report Filing (8-k)
5/09/201907:00GLOBEAthenex, Inc. Announces First Quarter 2019 Financial Results..
5/08/201917:06EDGARStatement of Changes in Beneficial Ownership (4)
5/08/201916:55EDGARInitial Statement of Beneficial Ownership (3)
5/08/201916:02EDGARAmended Statement of Ownership (sc 13g/a)
5/06/201908:06EDGARCurrent Report Filing (8-k)
5/06/201908:00GLOBEAthenex Announces $100 Million Private Placement
5/03/201909:12GLOBEAthenex Announces Promising Early and Complete Response Data..
4/25/201916:11EDGARStatement of Changes in Beneficial Ownership (4)
4/25/201907:03EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/25/201907:02EDGARProxy Statement (definitive) (def 14a)
4/25/201907:00GLOBEAthenex, Inc. to Report First Quarter 2019 Earnings Results..
See more news about this stock »


Your Recent History
NASDAQ
ATNX
Athenex
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.